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ABSTRACT
OBJECTIVE
To determine the relative effectiveness of dietary 
macronutrient patterns and popular named diet 
programmes for weight loss and cardiovascular risk 
factor improvement among adults who are overweight 
or obese.
DESIGN
Systematic review and network meta-analysis of 
randomised trials.
DATA SOURCES
Medline, Embase, CINAHL, AMED, and CENTRAL from 
database inception until September 2018, reference 
lists of eligible trials, and related reviews.
STUDY SELECTION
Randomised trials that enrolled adults (≥18 years) 
who were overweight (body mass index 25-29) or 
obese (≥30) to a popular named diet or an alternative 
diet.
OUTCOMES AND MEASURES
Change in body weight, low density lipoprotein 
(LDL) cholesterol, high density lipoprotein (HDL) 
cholesterol, systolic blood pressure, diastolic blood 
pressure, and C reactive protein at the six and 12 
month follow-up.
REVIEW METHODS
Two reviewers independently extracted data on 
study participants, interventions, and outcomes and 
assessed risk of bias, and the certainty of evidence 
using the GRADE (grading of recommendations, 
assessment, development, and evaluation) approach. 
A bayesian framework informed a series of random 
effects network meta-analyses to estimate the relative 
effectiveness of the diets.
RESULTS
121 eligible trials with 21 942 patients were included 
and reported on 14 named diets and three control 
diets. Compared with usual diet, low carbohydrate 
and low fat diets had a similar effect at six months on 
weight loss (4.63 v 4.37 kg, both moderate certainty) 
and reduction in systolic blood pressure (5.14 mm 
Hg, moderate certainty v 5.05 mm Hg, low certainty) 
and diastolic blood pressure (3.21 v 2.85 mm Hg,  
both low certainty). Moderate macronutrient diets 
resulted in slightly less weight loss and blood 
pressure reductions. Low carbohydrate diets had less 
effect than low fat diets and moderate macronutrient 
diets on reduction in LDL cholesterol (1.01 mg/dL, 
low certainty v 7.08 mg/dL, moderate certainty v 
5.22 mg/dL, moderate certainty, respectively) but 
an increase in HDL cholesterol (2.31 mg/dL, low 
certainty), whereas low fat (−1.88 mg/dL, moderate 
certainty) and moderate macronutrient (−0.89 mg/dL, 
moderate certainty) did not. Among popular named 
diets, those with the largest effect on weight 
reduction and blood pressure in comparison with 
usual diet were Atkins (weight 5.5 kg, systolic blood 
pressure 5.1 mm Hg, diastolic blood pressure 3.3 
mm Hg), DASH (3.6 kg, 4.7 mm Hg, 2.9 mm Hg, 
respectively), and Zone (4.1 kg, 3.5 mm Hg,  
2.3 mm Hg, respectively) at six months (all moderate 
certainty). No diets significantly improved levels of 
HDL cholesterol or C reactive protein at six months. 
Overall, weight loss diminished at 12 months among 
all macronutrient patterns and popular named diets, 
while the benefits for cardiovascular risk factors of 
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WHAT IS ALREADY KNOWN ON THIS TOPIC
A plethora of recommendations have suggested a variety of dietary programmes 
for weight management and cardiovascular risk reduction, primarily 
Mediterranean and DASH-style diets
Systematic reviews and meta-analyses of randomised trials have suggested that 
differences in weight loss between popular named diets are small and unlikely to 
be of importance to those seeking to lose weight, whereas meta-analyses have 
yielded conflicting results for cardiovascular risk reduction
Pairwise meta-analyses are limited in examining the relative merit of the range of 
popular named diets, and no comprehensive comparative effectiveness review, 
using network meta-analyses of diets for both weight loss and cardiovascular 
risk factors, has been carried out
WHAT THIS STUDY ADDS
Based on 121 randomised trials with 21 942 patients, low carbohydrate (eg, 
Atkins, Zone), low fat (eg, Ornish), and moderate macronutrient (eg, DASH, 
Mediterranean) diets had, compared with usual diet, compelling evidence for 
modest reduction in weight and potentially important reduction in both systolic 
and diastolic blood pressure at six months
Weight reduction at the 12 month follow-up diminished, and aside from the 
Mediterranean diet for LDL reduction, improvements in cardiovascular risk 
factors largely disappeared
Differences between diets were typically small to trivial and often based on low 
certainty evidence
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all interventions, except the Mediterranean diet, 
essentially disappeared.
CONCLUSIONS
Moderate certainty evidence shows that most 
macronutrient diets, over six months, result in 
modest weight loss and substantial improvements 
in cardiovascular risk factors, particularly blood 
pressure. At 12 months the effects on weight 
reduction and improvements in cardiovascular risk 
factors largely disappear.
SYSTEMATIC REVIEW REGISTRATION
PROSPERO CRD42015027929.
Introduction
The worldwide prevalence of obesity nearly tripled 
between 1975 and 2018.1 In response, authorities 
have made dietary recommendations for weight 
management and cardiovascular risk reduction.2 3 
Diet programmes—some focusing on carbohydrate 
reduction and others on fat reduction—have been 
promoted widely by the media and have generated 
intense debates about their relative merit. Millions of 
people are trying to lose weight by changing their diet. 
Thus establishing the effect of dietary macronutrient 
patterns (carbohydrate reduction v fat reduction v 
moderate macronutrients) and popular named dietary 
programmes is important.
Biological and physiological mechanisms have been 
proposed to explain why some dietary macronutrient 
patterns and popular dietary programmes should be 
better than others. A previous network meta-analysis, 
however, suggested that differences in weight loss 
between dietary patterns and individual popular 
named dietary programmes are small and unlikely to 
be important.4 No systematic review and network meta-
analysis has examined the comparative effectiveness of 
popular dietary programmes for reducing risk factors 
for cardiovascular disease, an area of continuing 
controversy.5-8
Proponents of Mediterranean-type and DASH-type 
(Dietary Approaches to Stop Hypertension) diets 
suggest that these diets can improve risk factors for 
cardiovascular disease through weight loss itself and 
owing to their limited sodium content and claimed 
anti-inflammatory properties.9 Systematic reviews 
and meta-analyses have shown conflicting results 
for the dietary effect on markers of cardiovascular 
disease risk, including blood pressure, low density 
lipoprotein (LDL) and high density lipoprotein (HDL) 
cholesterol, and C reactive protein.6 8-12 Few reviews 
have used rigorous meta-analytical techniques to obtain 
quantitative estimates of the relative effect of different 
diets.4 13 14 Systematic reviews have relied on pairwise 
comparisons. These comparisons have failed to examine 
direct and indirect clinical trial data by conducting a 
network meta-analysis, and they have not dealt with the 
certainty (quality) of evidence using the widely accepted 
standard, the GRADE (grading of recommendations, 
assessment, development, and evaluation) approach.15
We performed a systematic review and network 
meta-analysis of randomised controlled trials for 
improvements in weight loss and cardiovascular risk 
factors to determine the relative effectiveness and 
certainty of evidence among dietary macronutrient 
patterns and popular named dietary programmes for 
adults who are overweight or obese.
Methods
We searched Medline, Embase, CINAHL (Cumulative 
Index to Nursing and Allied Health Literature), AMED 
(Allied and Complementary Medicine Database), 
and the Cochrane Central Register of Controlled 
Trials (CENTRAL) from database inception until 
September 2018. Search terms included extensive 
controlled vocabulary and keyword searches related 
to randomised controlled trials, diets, weight loss, and 
cardiovascular risk factors. Appendix text S1 presents 
the Medline search strategy. We reviewed reference lists 
from eligible trials and related reviews for additional 
eligible randomised controlled trials.
Eligible studies randomised adults (≥18 years) who 
were overweight (body mass index 25-29) or obese 
(≥30) to an eligible popular named diet or an alternative 
active or non-active control diet (eg, usual diet), and 
reported weight loss, changes in lipid profile, blood 
pressure, or C reactive protein levels at three months’ 
follow-up or longer.
We categorised dietary treatment groups in two 
ways: using dietary macronutrient patterns (low 
carbohydrate, low fat, and moderate macronutrient—
similar to low fat, but slightly more fat and slightly less 
carbohydrate) and according to individual popular 
Study design Systematic review withnetwork meta-analysis
Heterogeneous participants, including
those with cardiovascular risk factors
Visual Abstract Do macronutrient diet patterns work?
Comparing  diets for weight and blood pressure reduction
Most macronutrient diets, over six months, resulted in modest weight 
loss and improved blood pressure. At  months, weight reduction 
diminished, and blood pressure improvements largely disappeared
Summary
Comparison Interventions Comparator
Usual diet
Dietary
advice
Low
carbohydrate
              such as
              Atkins, Zone
Low fat
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such as DASH,
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1
4
6
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named dietary programmes.4 Dietary macronutrient 
patterns were established by macronutrient content (see 
table 1). Leading dietary programmes were identified 
through the explicit naming of the branded or popular 
diet, the referencing of popular or branded literature, 
or the naming of a brand as a funder of a randomised 
controlled trial reporting our target outcomes. The diet 
was labelled as brand-like when it met the definition 
of a branded diet but failed to name or reference the 
brand in the article. For example, dietary programmes 
that did not refer to Atkins but consisted of less than 
40% of kilocalories from carbohydrates per day for 
the duration of study, or were funded by Atkins, were 
considered Atkins-like.16 17 Appendix table S1 presents 
the characteristics of eligible dietary programmes.
We included dietary programmes with structured 
advice for daily macronutrient, food, or caloric 
intake for a defined period (≥3 months). Eligible 
studies could or could not provide exercise (eg, 
walking, strength training) or behavioural support 
(eg, counselling, group support online or in person), 
and could include meal replacement products, but 
had to consist primarily of whole foods and could not 
include drugs.
We categorised eligible control diets as: usual 
diet (eg, wait list: participants were instructed to 
maintain their usual dietary habits), dietary advice 
(eg, received brochures, dietary materials including 
dietary guidelines, or consultation with a professional 
dietician by email or telephone), and low fat diet (≤30% 
fat with or without advice about lowering calories). We 
used the usual diet as our reference diet and presented 
results for the other diets against the reference diet.
Teams of two reviewers independently screened titles 
and abstracts for possible inclusion. If either reviewer 
considered a study potentially eligible, reviewers 
obtained and screened the full text. Reviewers resolved 
disagreements by discussion and, when necessary, 
through adjudication by a third reviewer.
Data abstraction and risk of bias assessment
After pilot testing our data extraction forms, teams of 
two reviewers independently extracted demographic 
information, experimental and control interventions 
including exercise and behavioural support, and 
data on each outcome of interest. We focused on two 
sets of outcomes: weight loss and related markers of 
cardiovascular disease risk (systolic blood pressure, 
diastolic blood pressure, LDL cholesterol, HDL 
cholesterol, and C reactive protein) at six and 12 month 
follow-up (±3 months for both periods).
Reviewers assessed the risk of bias for each 
individual randomised controlled trial independently 
and in duplicate using the Cochrane risk of bias tool.18 
We assigned individual trials as high risk of bias if one 
of two key domains, allocation concealment or missing 
outcome data, was deemed high risk of bias; otherwise, 
we assigned individual trials as low risk of bias.
Data synthesis and statistical methods
When reported, we used mean change and standard 
deviations. When authors reported data as measures 
before and after intervention, we used methods 
outlined in the Cochrane Handbook to calculate 
mean change and standard deviations for change.18 
When standard deviations were missing, we estimated 
them from standard errors, P values, confidence 
intervals, or graphs. If none of these methods was 
possible, we derived standard deviations from other 
studies included in our network meta-analysis using 
a validated imputation technique.19 Appendix text S2 
presents details of the missing standard deviations 
imputed for each outcome.
We performed statistical analyses for dietary macro-
nutrient patterns based on five nodes (moderate 
macronutrients, low carbohydrate, low fat, dietary 
advice, and usual diet) and for popular named 
diets based on 17 nodes (14 popular named dietary 
programmes and three control diets). We used 
bayesian random effects models to obtain the pooled 
direct estimates and corresponding forest plots of 
the available direct comparisons.20 We assessed 
heterogeneity between randomised controlled trials 
for each direct comparison with visual inspection of 
the forest plots and the I2 statistic.
We then performed a series of random effects network 
meta-analyses within a bayesian framework using 
Markov chain Monte-Carlo simulation methods.21 22 
For each analysis, we used three chains with 100 000 
iterations after an initial burn-in of 10 000. We 
assessed convergence based on trace plots and time 
series plots. We measured the goodness of model fit by 
the posterior mean of the overall residual deviance; in a 
well fitting model the residual deviance should be close 
to the number of data points included in the analysis.19 
We used vague priors and dealt with the extent of 
heterogeneity in each network analysis using a common 
heterogeneity variance (τ); we categorised results as 
low (from 0.1 to 0.5), moderate (>0.5 to 1.0), and high 
(>1.0).23 24 To estimate the precision of the effects, we 
used 95% credible intervals, by means of the 2.5 and 
97.5 percentiles obtained from the simulations.25 We 
Table 1 | Nutritional patterns based on macronutrient composition
Type of diet Popular diets* Carbohydrates, % kcal Protein, % kcal Fat, % kcal
Low carbohydrate Atkins, South Beach, Zone ≤40 Approximately 30 30-55
Moderate macronutrients Biggest Loser, DASH, Jenny Craig, Mediterranean, Portfolio, Slimming World, Volumetrics, Weight Watchers Approximately 55-60 Approximately 15 21-≤30
Low fat Ornish, Rosemary Conley† Approximately 60 Approximately 10-15 ≤20
1 kcal=4.18 kJ.
*A paleolithic diet was reported in two randomised controlled trials (Lindeberg 2007 and Mellberg 2014; appendix table S2), we categorised Lindeberg 2007 as moderate macronutrient based 
on energy intake (40.2±8.3% carbohydrate, 27.9±6.8% protein, 26.9±6.4% fat). Mellberg, 2014 was categorised as low carbohydrate (30% carbohydrate, 30% protein, 40% fat).
†We categorised Rosemary Conley diet (Truby 2006) as moderate macronutrient (42% carbohydrate, 16% protein, 37% fat).
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used the node splitting method to generate the effect 
size and credible intervals for the indirect comparison 
and for the statistical test of incoherence (also 
known as inconsistency) between direct and indirect 
estimates.26 We calculated the ranking probabilities of 
being the best, second best, and so on for all treatment 
options and used the surface under the cumulative 
ranking curve to rank the intervention hierarchy in the 
network meta-analysis.27
We considered two effect modifiers that were 
modelled as present or absent if they were included 
in an overall dietary programme: exercise and 
behavioural support. Exercise was defined as having 
explicit instructions for weekly physical activities and 
categorised as exercise or no exercise. Diets with at 
least two group or individual sessions a month for 
the first three months were considered to provide 
behavioural support.28 We performed a network 
meta-regression assuming a common coefficient 
across comparisons to explore the effect of exercise 
and behavioural support for each outcome.29 Three 
sensitivity analyses were conducted by restricting 
studies to trials with individuals who were overweight 
or obese, but who were otherwise healthy; those 
with a low risk of bias; and investigator initiated 
randomised trials, thus removing trials that were 
funded partly or wholly by diet companies.
We used the networkplot command of Stata version 
15.1 (StataCorp, College Station, TX) to draw the 
network plots,30 and WinBUGS version 1.4.3 (MRC 
Biostatistics Unit, Cambridge, UK) and R version 3.4.3 
(R Core Team, Vienna, Austria) with gemtc package 
for statistical analyses.
Assessing certainty of evidence
We rated the certainty of evidence for each network 
estimate using the GRADE framework, which classi-
fies evidence as high, moderate, low, or very low 
certainty. The starting point for certainty in direct 
estimates for randomised controlled trials is high, 
but could be rated down based on limitations in risk 
of bias, imprecision, inconsistency (heterogeneity), 
indirectness, and publication bias.15
We rated the certainty of evidence for each direct 
comparison according to standard GRADE guidance 
for pairwise meta-analysis.31 32 Indirect effect 
estimates were calculated from available “loops” of 
evidence, which included first order loops (based on 
a single common comparator treatment—that is the 
difference between treatment A and B is based on 
comparisons of A and C as well as B and C) or higher 
order loops (more than one intervening treatment 
connecting the two interventions). We assessed the 
evidence for indirect and network estimates focusing 
on the dominant first order loop,31 rating certainty of 
indirect evidence as the lowest certainty of the direct 
comparisons informing that dominant loop. In the 
absence of a first order loop, we used a higher order 
loop to rate certainty of evidence and used the lowest 
of the ratings of certainty for the direct estimates 
contributing to the loop. We considered further rating 
down each indirect comparison for intransitivity if 
the distribution of effect modifiers differed in the 
contributing direct comparisons.31
For the network estimate, we started with the 
certainty of evidence from the direct or indirect 
evidence that dominated the comparison and, sub-
sequently, considered rating down our certainty 
in the network estimate for incoherence between 
the indirect and direct estimates for imprecision 
(wide credible intervals) around the treatment effect 
estimates. When serious incoherence was present, 
we used, as the best estimate, that with the higher 
certainty of the direct and indirect evidence.32 
Appendix text S3 presents additional details of the 
GRADE assessment.
Summary of more and less preferred treatments
To optimise the presentation of results for the 17 diet 
(14 popular, three control) network meta-analysis, 
we applied a new approach to summarise the results, 
establishing different groups of interventions (from 
the most to the least effective) based on the effect 
estimates obtained from the meta-analysis and their 
certainty of evidence.33 For each outcome, we created 
three groups of interventions. Firstly, the reference 
diet (usual diet) and diets that did not differ from the 
reference (that is, confidence interval crossed mean 
difference=0), which we refer to as “among the least 
effective”. Secondly, diets superior to the reference, 
but not superior to any other diet superior to the 
reference (which we call category 1 and describe as 
“inferior to the most effective, but superior to the least 
effective”). Lastly, diets that proved superior to at least 
one category 1 diet (which we call “among the most 
effective”). We then divided all three categories into 
two groups: those with moderate or high certainty 
evidence relative to the usual diet, and those with low 
or very low certainty evidence relative to the usual diet.
Patient and public involvement
No patients were involved in setting the research 
question or the outcome measures, in developing 
plans for design or implementation of the study, or in 
the interpretation or write up of results. We did not 
evaluate whether the studies included in the review 
involved patients in planning or implementing the 
study.
Results
Search
The electronic searches yielded 27 238 unique 
studies, and the grey literature search identified 213 
additional studies. Of the total, 1411 were potentially 
eligible, and 137 articles reporting 121 randomised 
controlled trials proved eligible (fig 1). Appendix text 
S4 presents the list of eligible studies.
Study characteristics, risk of bias, and certainty of 
evidence
Appendix table S2 summarises the characteristics of 
the 121 randomised controlled trials, which included 
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from 21 to 1269 participants (total 21 942) with a 
median of mean age of 49.0 years, a median of mean 
body mass index of 33.0, a median of mean weight 
of 92.9 kg, a median proportion of women of 69.0%, 
and a median intervention duration of 26 weeks. 
Figure 2 provides the network plot of macronutrient 
consumption patterns and the popular named diets. 
Appendix figures S1-S6 present the network plot for 
each outcome, appendix table S3 presents the number 
of studies and participants for the popular named diets 
for all outcomes, and appendix table S4 summarises 
the funding sources and primary and secondary 
outcomes reported in included trials.
Ninety four randomised controlled trials were at low 
risk of bias and 27 were at high risk of bias (appendix 
table S5).
For the outcomes of weight and blood pressure, 
many comparisons of popular diets versus the 
reference standard, usual diet, provided moderate 
certainty evidence. For other outcomes, and for most 
comparisons of popular diets against one another, 
results provided only low certainty evidence.
Provided by industry contacts
Articles excluded
Not target intervention
Duplicates
Abstract only
Non-randomised controlled trial
Not target population
Not outcomes of interest
Non-English
591
295
113
129
78
44
24
Titles and abstracts screened
Potentially relevant titles and abstracts
Not relevant
Articles for full text review
Articles included (121 unique studies)
213
22 252
Duplicates
23 663
137
3788
1411
1274
27 238
Fig 1 | Flow diagram of literature selection
Dietary advice
Low carbohydrate
Low fat
Moderate
macronutrients
Usual diet
Atkins
Biggest Loser
DASH
Dietary advice
Jenny
Craig
Low fat
Mediterranean
Ornish
Paleolithic
Portfolio
Rosemary Conley
Slimming World
South Beach
Usual diet
Volumetrics
Weight Watchers
Zone
Fig 2 | Network plots of all included studies for macronutrient patterns and popular named diets
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Dietary macronutrient patterns
Appendix tables S6-S11 present GRADE assessments for 
all outcomes at six months (±3 months), with the number 
of included randomised controlled trials, sample size, I2, 
direct estimates, indirect estimates, intransitivity, and 
incoherence assessment. Much of the evidence was 
judged as moderate certainty, rated down most often 
because of serious inconsistency. Compared with a usual 
diet, low carbohydrate diets had median differences in 
weight loss of 4.63 kg (95% credible interval 3.42 to 5.87; 
moderate certainty; fig 3), a reduction in systolic blood 
pressure of 5.14 mm Hg (3.01 to 7.32; moderate certainty; 
fig 4), a reduction in diastolic blood pressure of 3.21 mm 
Hg (1.89 to 4.53; low certainty; fig 4), an increase in HDL 
cholesterol of 2.31 mg/dL (0.68 to 3.87; low certainty; 
fig 5), and a reduction in LDL cholesterol of 1.01 mg/dL 
(−2.96 to 4.96 mg/dL; low certainty; fig 5). Low fat diets 
had estimated effects similar to those of low carbohydrate 
diets for weight loss (fig 3) and blood pressure (fig 
4), but a greater effect on LDL cholesterol reduction 
(7.08 mg/dL; moderate certainty; fig 5). Based on 
moderate to low certainty evidence, moderate macro-
nutrient diets had slightly smaller effects than low 
carbohydrate diets on weight loss (fig 3), blood pressure 
(fig 4), and HDL cholesterol increase (fig 5), but a greater 
effect on LDL cholesterol reduction (fig 5). Appendix 
table S12 presents the network meta-analysis results for 
C reactive protein, showing no statistically significant 
differences between diets.
At the 12 month (±3 months) follow-up, the estimated 
average weight loss of all dietary macronutrient 
patterns compared with usual diet was 1 to 2 kg less, 
generally with low certainty evidence (appendix table 
S13). We found no significant differences between 
the macronutrient dietary patterns and usual diet for 
systolic and diastolic blood pressure, LDL cholesterol, 
and C reactive protein reductions, except low fat 
and moderate macronutrients, which each showed 
significant adverse reductions in HDL cholesterol 
(−2.90 mg/dL, −2.81 mg/dL, respectively; appendix 
tables S12, S14, and S15).
Appendix tables S16-S25 present sensitivity analyses 
showing that the findings were similar to those of the 
primary analyses. Network meta-regression accounting 
for both exercise and behaviour support also showed 
similar results (appendix tables S26-S28).
Individual popular named diets
Appendix tables S29-S34 present the GRADE 
assessment details for all outcomes at six months (±3 
months). Figure 6 and appendix table S35 summarise 
the results for all outcomes at six months in comparison 
with a usual diet, organised by GRADE certainty of 
evidence.
Weight loss
Appendix table S36 presents the league table of 
weight loss at six months. Among the diets with high 
or moderate certainty evidence relative to usual diet, 
Jenny Craig and Atkins proved the most effective 
popular named diets, whereas Volumetrics, paleolithic, 
low fat, Zone, Weight Watchers, Rosemary Conley, 
DASH, Ornish, and Mediterranean were inferior to the 
most effective but superior to the least effective diet 
interventions. The Biggest Loser, Slimming World, and 
dietary advice were the least effective diet interventions 
(fig 6, appendix table S35). Among the diets with only 
low or very low certainty evidence relative to usual 
diet, South Beach might be the most effective (fig 6).
All named diets, except a paleolithic diet, decreased 
their estimated effects at the 12 month follow-up by, on 
average, 1.5 kg compared with the six month follow-up 
(appendix tables S36 and S37).
Systolic blood pressure
Appendix table S38 presents the league table of 
reduction of systolic blood pressure at six months. 
Among the diets with moderate certainty evidence 
relative to a usual diet, paleolithic was probably the 
most effective, whereas Atkins, DASH, Portfolio, low 
fat, Zone, and Mediterranean were probably inferior to 
the most effective, but superior to the least effective, 
Usual
diet
Dietary
advice
0.02 (-1.71 to 1.76)
4.37 (3.03 to 5.74) 4.35 (2.56 to 6.15)
4.63 (3.42 to 5.87) 4.61 (3.01 to 6.23) 0.26 (-0.92 to 1.45)
3.06 (2.04 to 4.10) 3.04 (1.60 to 4.48) -1.31 (-2.40 to -0.22) -1.57 (-2.29 to -0.86)
High certainty Moderate certainty Low certainty Very low certainty
Low
fat
Low
carbohydrate
Moderate
macronutrients
Fig 3 | Macronutrient pattern network meta-analysis results with corresponding GRADE (grading of recommendations, 
assessment, development, and evaluation) certainty of evidence for six month weight loss (kg). Values correspond to 
difference in median weight loss between column and row at six months, for positive values the diet indicated in the 
column is favoured (eg, low fat had a median weight loss of 4.37 kg at six months compared with usual diet). Values in 
bold indicate a statistically significant treatment effect
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diets. The Biggest Loser and Ornish proved the least 
effective diets. Among the diets with only low or very 
low certainty evidence relative to usual diet, Jenny Craig 
might be the most effective (fig 6, appendix table S35).
Effects for all popular named diet programmes had 
decreased at the 12 month follow-up compared with 
the six month follow-up. No statistically significant 
differences were found between popular named diets 
and a usual diet (appendix tables S38 and S39).
Diastolic blood pressure
Among the diets with moderate certainty evidence 
relative to a usual diet, Atkins proved the most effective 
popular named diet at six months, whereas DASH, 
low fat, and Zone were probably inferior to the most 
effective, but superior to the least effective, diets. 
Paleolithic, Biggest Loser, Mediterranean, and Ornish 
proved the least effective diets. Among the diets with 
only low or very low certainty evidence relative to 
a usual diet, Jenny Craig might be the most effective 
(fig 6, appendix tables S35 and S38). We found no 
statistically significant differences between popular 
named diets and usual diet at the 12 month follow-up 
(appendix table S39).
Blood lipoproteins
Among the diets with moderate certainty evidence 
relative to usual diet, the Mediterranean diet proved 
the most effective popular named diet for LDL 
cholesterol reduction; Ornish, DASH, Biggest Loser, 
low fat, and dietary advice were probably no better 
than usual diet. Among the diets with only low or 
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Fig 4 | Macronutrient pattern network meta-analysis results with corresponding GRADE (grading of recommendations, 
assessment, development, and evaluation) certainty of evidence for six month systolic blood pressure (SBP) and 
diastolic blood pressure (DBP) reduction (mm Hg). Values correspond to difference in median DBP reduction (above, 
right of macronutrient patterns) and SBP reduction (below, left of macronutrient patterns) between column and row at 
six months (eg, low fat had a median DBP reduction of 1.80 and a median SBP reduction of 3.59 compared with dietary 
advice). Values in bold indicate a statistically significant treatment effect
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Fig 5 | Macronutrient pattern network meta-analysis results with corresponding GRADE (grading of recommendations, 
assessment, development, and evaluation) certainty of evidence for reduction in low density lipoprotein (LDL) 
cholesterol and increase in high density lipoprotein (HDL) cholesterol (mg/dL) at six months. Values correspond to 
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(below, left of macronutrient patterns) between column and row at six months (eg, low fat had a median HDL 
cholesterol increase of 0.10 mg/dL and a median LDL cholesterol reduction of 5.47 mg/dL at six months compared 
with dietary advice). Values in bold indicate a statistically significant treatment effect
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very low certainty evidence relative to a usual diet, 
Portfolio might be the most effective (fig 6, appendix 
tables S35 and S40).
No popular named diets showed a statistically 
significant increase in HDL cholesterol at the six 
month follow-up (fig 6, appendix tables S35 and 
S40). Similar, but smaller, results were found at the 
12 month follow-up for both LDL and HDL cholesterol 
(appendix table S41).
C reactive protein
We found no statistically significant differences bet-
ween popular named diets and usual diet (fig 6, 
appendix tables S35 and S42). Similar results were 
found at the 12 month follow-up (appendix table S43).
Additional analyses
Appendix figure S7 presents the results of mean 
surface under the cumulative ranking curve values 
for all outcomes at six months. We did not perform 
network meta-regressions and sensitivity analyses for 
C reactive protein because of the limited number of 
eligible randomised controlled trials. Network meta-
regressions for the other five outcomes showed that 
none of the regression factors (behavioural support and 
exercise, risk of bias, clinical population, and funding 
support) had statistically significant effects. Appendix 
tables S44-S57 present the results of network meta-
regressions and sensitivity analyses.
Adverse events
Twenty two (18.2%) of the 121 randomised controlled 
trials, of which 12 evaluated low carbohydrate 
diets, reported adverse events. One trial reported 
a statistically significant higher risk of headaches 
at three months (25% v 8%; P=0.03) in the group 
receiving a low fat diet (n=73) than in the group with 
a low carbohydrate diet (n=75), but no significant 
differences at six and 12 months.34 Another trial 
reported a statistically significant increase in the risk 
of several adverse effects at six months in the group 
assigned to a low carbohydrate diet (n=60) than in 
those assigned to a low fat diet (n=60), including 
constipation (68% v 35%; P=0.001), headache (60% v 
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Fig 6 | Summary of results of popular named diets network meta-analysis for all outcomes at six months. The number 
is the point estimates of effect in comparison with usual diet
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40%; P=0.03), halitosis (38% v 8%; P=0.001), muscle 
cramps (35% v 7%; P=0.001), diarrhoea (23% v 7%; 
P=0.02), general weakness (25% v 8%; P=0.01), 
and rash (13% v 0%; P=0.006).35 Study authors did 
not assess the likelihood that the diet was plausibly 
responsible for the adverse events.
Discussion
Our network meta-analysis quantifies the comparative 
effectiveness of three dietary macronutrient patterns 
based on 14 popular named dietary programmes for 
both weight and related cardiovascular risk factors 
at six and 12 months using the GRADE approach. 
Evidence of low to moderate certainty showed 
that all three dietary macronutrient patterns (low 
carbohydrate, low fat, and moderate macronutrient) 
were associated with larger reductions in body weight 
(fig 3) and blood pressure than a usual diet (fig 4); 
reductions with moderate macronutrient diets were 
slightly smaller than with the other two macronutrient 
patterns. Effects on weight were less at 12 months than 
at six months (between 4 and 5 kg reductions relative 
to usual diet at six months, about 3 kg at 12 months). 
Based on moderate certainty evidence, both low fat 
and moderate macronutrient diets are likely to reduce 
LDL cholesterol relative to usual diets at six months. 
All these changes were potentially important based 
on the importance threshold we specified in advance 
(weight loss 2 kg, systolic blood pressure 3 mm Hg, 
diastolic blood pressure 2 mm Hg, LDL cholesterol 
5 mg/dL; appendix text S3). Macronutrient diet related 
improvements in both blood pressure and blood lipids 
disappeared almost completely at 12 months.
Of the popular named diets, Atkins, DASH, and 
Zone had the highest certainty evidence and the most 
consistent effects for reduction in weight and blood 
pressure at six months; an unnamed diet, low fat, 
performed similarly to the named diets (fig 6). Only the 
Mediterranean diet showed a statistically significant 
difference compared with usual diet in LDL cholesterol 
reduction (fig 6). Estimated effects at the 12 month 
follow-up for weight loss and cardiovascular risk factor 
improvements diminished for all popular named diets, 
except for the Mediterranean diet. None of the diets 
were associated with a statistically significant increase 
in HDL cholesterol or reduction in C reactive protein at 
either the six or 12 month follow-up.
Network meta-analyses showed that although there 
were statistically significant differences between some 
dietary patterns, these differences were generally 
small at six months and negligible at 12 months. For 
example, low carbohydrate dietary patterns resulted in 
an estimated difference in weight loss of 1.57 kg (95% 
credible interval 0.86 to 2.29), a reduction in systolic 
blood pressure of 1.66 mm Hg (0.36 to 2.98), and a 
reduction in diastolic blood pressure of 1.33 mm Hg 
(0.51 to 2.16) compared with moderate macronutrient 
dietary patterns at six months (fig 3, fig 4, and fig 5).
The same small differences between diets at six 
months and even smaller and uncertain differences 
at 12 months apply to the popular named diets. For 
instance, Atkins resulted in an estimated difference 
in weight loss of only 1.38 kg (95% credible interval 
0.15 to 2.62) and an LDL cholesterol reduction of 
−0.15 mg/dL (−4.92 to 4.63 mg/dL) compared with the 
Zone diet at the six month follow-up (appendix tables 
S36 and S40). Figure 6 highlights instances in which 
differences exist, all of which are small or even trivial, 
with the corresponding certainty of the underlying 
evidence.
Strengths and limitations of this review
Strengths of this review include our use of network 
meta-analysis, thus taking advantage of both direct 
and indirect comparisons to generate the most robust 
estimates possible of weight and cardiovascular risk 
factors for both dietary macronutrient patterns and 
individual popular named diets. We used explicit 
eligibility criteria; conducted a comprehensive lit-
erature search developed with an experienced 
librarian; performed duplicate assessment of study 
eligibility, risk of bias, and data extraction; sum-
marised the data using a transparent statistical 
analysis including network meta-regression accoun-
ting for potential effect modifiers (eg, exercise and 
behavioural support); applied the GRADE approach 
to rate certainty of evidence; presented tables of 
results highlighting certainty of evidence; and used 
an innovative classification scheme enhancing the 
transparency of the relative effects of the named diets 
across multiple outcomes (fig 6). Furthermore, to 
reduce the heterogeneity between studies, we used 
three categories for control diets: usual diet, dietary 
advice, and low fat diet; the low fat diet proved to have 
moderate certainty evidence supporting weight and 
blood pressure reductions, similar to the named diets. 
We conducted sensitivity analyses by restricting them 
to studies assessed as low risk of bias, studies focusing 
on otherwise healthy populations, and studies without 
diet company (industry) support. All analyses provided 
results similar to those of our primary analysis, further 
supporting the robustness of our results.
Our review has some limitations. Firstly, many 
comparisons provided only low certainty evidence, 
primarily because of inconsistency and imprecision, 
but also because of risk of bias. The paucity of direct 
comparisons between popular named diets contributed 
to the low certainty evidence: 14 popular named 
diet programmes included 407 paired comparisons 
across six outcomes, of which only 59 made direct 
comparisons, and, of these, only 22 included more 
than one study. Secondly, our ability to deal with 
publication bias was limited given the paucity of direct 
comparisons. For example, only two of 136 comparison 
groups (Atkins v low fat, and Zone v low fat) had more 
than 10 studies for the outcome weight loss. Thirdly, 
we did not involve patients in either the planning or 
the conduct of the study. Fourthly, considerably fewer 
trials reported our target outcomes at the 12 month 
follow-up, and most of the evidence was low to very 
low certainty (appendix tables S58-S63). Fifthly, 
adherence to diets was generally not reported, and 
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could have been low, particularly at 12 months. If this 
is the case, our results describe what is likely to happen 
for average adherence by patients. Full adherence 
would probably yield larger effects in improvement 
of weight loss and cardiovascular risk factors. If the 
weight loss achieved at six months continued at 12 
months, it is uncertain whether the improvements in 
cardiovascular risk factors would also be maintained. 
Future studies, therefore, could usefully examine 
how to achieve longer term adherence to diets. Lastly, 
participants in randomised trials are always a select 
population. Selection could be more important in 
dietary trials than in trials in which effects are less tied 
to individual behaviour. Whether trial non-participants 
would be more, or less, adherent to the popular named 
diets is, however, a matter of speculation.
Comparison with other studies
Our review examined weight loss and cardiovascular 
risk factors among dietary macronutrient patterns and 
popular named diets using new network meta-analysis 
methods and the GRADE approach to summarise 
the certainty of evidence. In comparison with our 
previous network meta-analysis that examined weight 
loss alone,4 we included three additional popular 
diets (DASH, Portfolio, Mediterranean). Altogether, 
we included 73 additional randomised controlled 
trials, resulting in almost three times the number of 
participants included in the previous trial.
Consistent with our previous review, results 
indicated that almost all dietary patterns and popular 
named diets showed a minimally clinical important 
weight loss of 2.0 kg compared with a usual diet for 
up to 12 months, with the differences among diets, for 
the most part, small and often trivial.4 Our findings are 
also consistent with the 2014 joint guidelines from the 
American Heart Association, the American College of 
Cardiology, and The Obesity Society, concluding that 
evidence was inadequate to recommend any particular 
diet.3 Similar to another recent review,36 our results 
showed that the Atkins diet probably achieves the 
largest weight loss, although the gradient of weight or 
cardiovascular risk factor improvement relative to other 
diets is small. For reduction of cardiovascular risk, 
recent dietary guidelines from the US and Canada, and 
the EAT Lancet commission have recommended plant 
based diets.37-39 To the extent that short term results 
might have implications for long term cardiovascular 
outcomes, our findings do not support this conclusion: 
rather, they suggest that omnivorous based diets (eg, 
Atkins, Zone) have a similar effect to diets that tend 
to be higher in plant based foods (eg, Ornish, DASH, 
Mediterranean).
Conclusions
Compared with usual diet, moderate certainty 
evidence supports modest weight loss and substantial 
reductions in systolic and diastolic blood pressure 
for low carbohydrate (eg, Atkins, Zone), low fat (eg, 
Ornish), and moderate macronutrient (eg, DASH, 
Mediterranean) diets at six but not 12 months. 
Differences between diets are, however, generally 
trivial to small, implying that people can choose the 
diet they prefer from among many of the available 
diets (fig 6) without concern about the magnitude of 
benefits.
AUTHOR AFFILIATIONS
1Evidence Based Social Science Research Centre, School of Public 
Health, Lanzhou University, Lanzhou, China
2Department of Social Medicine and Health Management, School of 
Public Health, Lanzhou University, Lanzhou, China
3Department of Health Research Methods, Evidence and Impact, 
McMaster University, Hamilton, ON, Canada
4Michael G DeGroote Institute for Pain Research and Care, 
McMaster University, Hamilton, ON, Canada
5Department of Pediatrics, University of Alberta, Edmonton, AB, 
Canada
6Institute of Primary Health Care (BIHAM), University of Bern, Bern, 
Switzerland
7Applied Health Research Centre, St Michael’s Hospital, University 
of Toronto, Toronto, ON, Canada
8Institute of Health Policy, Management and Evaluation, University 
of Toronto, Toronto, ON, Canada
9Department of Community Health and Epidemiology, Faculty of 
Medicine, Dalhousie University, Halifax, NS, Canada
10Zucker School of Medicine at HOFSTRA/Northwell Mather 
Hospital, Port Jefferson, NY, USA
11School of Medicine, Wayne State University, Detroit, MI, USA
12School of Population and Public Health, University of British 
Columbia, Vancouver, BC, Canada
13HIV/STI Surveillance Research Centre, and WHO Collaborating 
Centre for HIV Surveillance, Institute for Futures Studies in Health, 
Kerman University of Medical Sciences, Kerman, Iran
14Library and Archives Services, The Hospital for Sick Children, 
Toronto, ON, Canada
15Department of Medicine, University of Toronto, Toronto, ON, 
Canada
16Department of Agricultural, Food, and Nutritional Sciences, 
University of Alberta, Edmonton, AB, Canada
17Institute of Social and Preventive Medicine (ISPM), University of 
Bern, Bern, Switzerland
18Department of Pharmacology, Faculty of Medicine and Dentistry, 
University of Alberta, Edmonton, AB, Canada
19Evidence Based Medicine Centre, School of Basic Medical 
Sciences, Lanzhou University, Lanzhou, China
20Department of Nutrition, Texas A&M University, College Station, 
TX, 77845, USA
We thank Kristian Thorlund (McMaster University) for supporting the 
development of the original statistical code for our analysis, and Bei 
Pan (Gansu Provincial Hospital), Liangying Hou (School of Public 
Health, Lanzhou University), and Huijuan Li (School of Public Health, 
Lanzhou University) for help with cleaning data, data analysis, and 
table preparation.
Contributors: BCJ, GDCB, and BS conceived the study. BCJ, GDCB, 
CLH, BS, LG, BRdC, RTT, and GHG designed the study protocol. TA-W, 
BS, and BCJ designed and performed the search strategy. BS, LG, 
CLH, RK, KQ, HYK, MK, WA, SD, DZ, and AN screened abstracts and full 
texts, extracted data, or judged risk of bias of included studies. LG, 
AS, AN, and BRdC performed the data analysis. LG, BCJ, BS, GHG, JT, 
and KY designed and performed the GRADE assessment. LG, BS, and 
BCJ wrote the first draft of the manuscript. LG, BS, GDCB, CLH, RTT, 
GHG, and BCJ provided administrative, technical, or material support. 
BCJ, GDCB, BS, BRdC, and GHG supervised the study. All authors 
interpreted the data analysis and critically revised the manuscript. BCJ 
and LG are the guarantors. The corresponding author attests that all 
listed authors meet authorship criteria and that no others meeting the 
criteria have been omitted.
Funding: This research was not funded by a specific grant from any 
funding agency in the public, commercial, or not-for-profit sectors. 
It was funded, in part, by internal investigator funds from Dalhousie 
University (awarded to BCJ) and the University of Alberta (awarded 
to GDCB). SD was supported by a scholarship from Umm AlQura 
 o
n
 8 April 2020 at Universitaetsbibliothek Bern. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.m696 on 1 April 2020. Downloaded from 
RESEARCH
the bmj | BMJ 2020;369:m696 | doi: 10.1136/bmj.m696 11
University, Makkah, Kingdom of Saudi Arabia. GDCB was supported by 
an Alberta Health Services Chair in Obesity Research.
Competing interests: All authors have completed the ICMJE uniform 
disclosure form at www.icmje.org/coi_disclosure.pdf (available 
on request from the first author) and declare: no support from any 
organisation for the submitted work. BS reports funding from Mitacs 
Canada in the past three years, and the International Life Sciences 
Institute (ILSI), North America to support his graduate work for his 
2015 academic year (the ILSI funding is outside the required three 
year period requested on the ICJME form). In 2016-17, BS worked for 
the Cornerstone Research Group, a contract research organisation. 
AS reports personal fees from Dalhousie University. RTT reports 
grants from Sanofi Canada, outside the submitted work. As part of his 
recruitment to Texas A&M University, BCJ receives funds from Texas 
A&M AgriLife Research to support investigator initiated research 
related to saturated and polyunsaturated fats. Support from Texas 
A&M AgriLife institutional funds are from interest and investment 
earnings, not a sponsoring organisation, industry, or company. BCJ 
also received funding in 2015 from ILSI (outside the required three 
year period requested on ICJME form) to assess the methodological 
quality of nutrition guidelines dealing with sugar intake using 
internationally accepted GRADE (grading of recommendations, 
assessment, development, and evaluation) and AGREE (appraisal 
of guidelines for research and evaluation) guideline standards. The 
authors conducted the review of methodological quality of nutrition 
guidelines independently without involvement of the funder. No other 
relationships or activities that could appear to have influenced the 
submitted work.
Ethical approval: Not required.
Data sharing: All data are freely available within the appendices. No 
additional data available.
The manuscript’s guarantors (BCJ and LG) affirm that the manuscript 
is an honest, accurate, and transparent account of the study being 
reported; that no important aspects of the study have been omitted; 
and that any discrepancies from the study as planned (and, if relevant, 
registered) have been explained.
Dissemination to participants and related patient and public 
communities: We plan to disseminate the results to relevant patient 
communities through the media relations department of our 
institutions.
This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this work 
non-commercially, and license their derivative works on different 
terms, provided the original work is properly cited and the use is non-
commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
1  World Health Organization. Obesity and overweight, Fact sheet. 
2018. https://www.who.int/mediacentre/factsheets/fs311/en/
2  Freedhoff Y, Hall KD. Weight loss diet studies: we need help not hype. 
Lancet 2016;388:849-51. doi:10.1016/S0140-6736(16)31338-1
3  Jensen MD, Ryan DH, Apovian CM, et al, American College of 
Cardiology/American Heart Association Task Force on Practice 
Guidelines, Obesity Society. 2013 AHA/ACC/TOS guideline for 
the management of overweight and obesity in adults: a report of 
the American College of Cardiology/American Heart Association 
Task Force on Practice Guidelines and The Obesity Society. 
Circulation 2014;129(Suppl 2):S102-38. doi:10.1161/01.
cir.0000437739.71477.ee 
4  Johnston BC, Kanters S, Bandayrel K, et al. Comparison of weight 
loss among named diet programs in overweight and obese 
adults: a meta-analysis. JAMA 2014;312:923-33. doi:10.1001/
jama.2014.10397 
5  Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K. Effects of low-
carbohydrate diets v. low-fat diets on body weight and cardiovascular 
risk factors: a meta-analysis of randomised controlled trials. Br J 
Nutr 2016;115:466-79. doi:10.1017/S0007114515004699
6  Naude CE, Schoonees A, Senekal M, Young T, Garner P, Volmink J. 
Low carbohydrate versus isoenergetic balanced diets for reducing 
weight and cardiovascular risk: a systematic review and meta-
analysis [correction in: PLoS One 2018;13:e0200284]. PLoS 
One 2014;9:e100652. doi:10.1371/journal.pone.0100652 
7  Sackner-Bernstein J, Kanter D, Kaul S. Dietary intervention for 
overweight and obese adults: comparison of low-carbohydrate 
and low-fat diets. a meta-analysis. PLoS One 2015;10:e0139817. 
doi:10.1371/journal.pone.0139817
8  Schwingshackl L, Hoffmann G. Long-term effects of low-fat diets 
either low or high in protein on cardiovascular and metabolic risk 
factors: a systematic review and meta-analysis. Nutr J 2013;12:48. 
doi:10.1186/1475-2891-12-48
9  Zhong X, Guo L, Zhang L, Li Y, He R, Cheng G. Inflammatory potential 
of diet and risk of cardiovascular disease or mortality: a meta-
analysis. Sci Rep 2017;7:6367. doi:10.1038/s41598-017-06455-x
10  Bloomfield HE, Koeller E, Greer N, MacDonald R, Kane R, Wilt 
TJ. Effects on health outcomes of a mediterranean diet with no 
restriction on fat intake: a systematic review and meta-analysis. Ann 
Intern Med 2016;165:491-500. doi:10.7326/M16-0361 
11  Siervo M, Lara J, Chowdhury S, Ashor A, Oggioni C, Mathers JC. 
Effects of the Dietary Approach to Stop Hypertension (DASH) diet on 
cardiovascular risk factors: a systematic review and meta-analysis. Br 
J Nutr 2015;113:1-15. doi:10.1017/S0007114514003341
12  Soltani S, Chitsazi MJ, Salehi-Abargouei A. The effect of dietary 
approaches to stop hypertension (DASH) on serum inflammatory 
markers: A systematic review and meta-analysis of randomized trials. 
Clin Nutr 2018;37:542-50. doi:10.1016/j.clnu.2017.02.018 
13  Huedo-Medina TB, Garcia M, Bihuniak JD, Kenny A, Kerstetter J. 
Methodologic quality of meta-analyses and systematic reviews on the 
Mediterranean diet and cardiovascular disease outcomes: a review. 
Am J Clin Nutr 2016;103:841-50. doi:10.3945/ajcn.115.112771 
14  Barnard ND, Willett WC, Ding EL. The misuse of meta-analysis 
in nutrition research. JAMA 2017;318:1435-6. doi:10.1001/
jama.2017.12083
15  Guyatt GH, Oxman AD, Vist GE, et al, GRADE Working Group. 
GRADE: an emerging consensus on rating quality of evidence and 
strength of recommendations. BMJ 2008;336:924-6. doi:10.1136/
bmj.39489.470347.AD
16  Stern L, Iqbal N, Seshadri P, et al. The effects of low-carbohydrate 
versus conventional weight loss diets in severely obese adults: one-
year follow-up of a randomized trial. Ann Intern Med 2004;140:778-
85. doi:10.7326/0003-4819-140-10-200405180-00007
17  Volek JS, Ballard KD, Silvestre R, et al. Effects of dietary 
carbohydrate restriction versus low-fat diet on flow-mediated 
dilation. Metabolism 2009;58:1769-77. doi:10.1016/j.
metabol.2009.06.005
18  Higgins JPT, Green S (eds). Cochrane handbook for systematic reviews 
of interventions. Version 5.1.0 [updated March 2011]. Cochrane 
Collaboration, 2011. www.handbook.cochrane.org.
19  Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. 
Imputing missing standard deviations in meta-analyses can provide 
accurate results. J Clin Epidemiol 2006;59:7-10. doi:10.1016/j.
jclinepi.2005.06.006 
20  Dias S, Sutton AJ, Welton NJ, Ades AE. Evidence synthesis for 
decision making 3: heterogeneity--subgroups, meta-regression, 
bias, and bias-adjustment. Med Decis Making 2013;33:618-40. 
doi:10.1177/0272989X13485157
21  Ades AE, Sculpher M, Sutton A, et al. Bayesian methods 
for evidence synthesis in cost-effectiveness analysis. 
Pharmacoeconomics 2006;24:1-19. doi:10.2165/00019053-
200624010-00001
22  Lumley T. Network meta-analysis for indirect treatment comparisons. 
Stat Med 2002;21:2313-24. doi:10.1002/sim.1201
23  Turner RM, Davey J, Clarke MJ, Thompson SG, Higgins JP. Predicting 
the extent of heterogeneity in meta-analysis, using empirical 
data from the Cochrane Database of Systematic Reviews. Int J 
Epidemiol 2012;41:818-27. doi:10.1093/ije/dys041
24  Rhodes KM, Turner RM, Higgins JP. Predictive distributions were 
developed for the extent of heterogeneity in meta-analyses of 
continuous outcome data. J Clin Epidemiol 2015;68:52-60. 
doi:10.1016/j.jclinepi.2014.08.012 
25  Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks 
of randomized trials. Stat Methods Med Res 2008;17:279-301. 
doi:10.1177/0962280207080643
26  van Valkenhoef G, Dias S, Ades AE, Welton NJ. Automated generation 
of node-splitting models for assessment of inconsistency in network 
meta-analysis. Res Synth Methods 2016;7:80-93. doi:10.1002/
jrsm.1167
27  Veroniki AA, Straus SE, Fyraridis A, Tricco AC. The rank-heat plot is 
a novel way to present the results from a network meta-analysis 
including multiple outcomes. J Clin Epidemiol 2016;76:193-9. 
doi:10.1016/j.jclinepi.2016.02.016
28  US Preventive Services Task Force. Screening for obesity in adults: 
recommendations and rationale. Ann Intern Med 2003;139:930-2. 
doi:10.7326/0003-4819-139-11-200312020-00012
29  Chaimani A, Salanti G. Using network meta-analysis to evaluate the 
existence of small-study effects in a network of interventions. Res 
Synth Methods 2012;3:161-76. doi:10.1002/jrsm.57
30  Chaimani A, Higgins JP, Mavridis D, Spyridonos P, Salanti G. Graphical 
tools for network meta-analysis in STATA. PLoS One 2013;8:e76654. 
doi:10.1371/journal.pone.0076654
31  Puhan MA, Schünemann HJ, Murad MH, et al, GRADE Working Group. 
A GRADE Working Group approach for rating the quality of treatment 
effect estimates from network meta-analysis. BMJ 2014;349:g5630. 
doi:10.1136/bmj.g5630
32  Brignardello-Petersen R, Bonner A, Alexander PE, et al, GRADE 
Working Group. Advances in the GRADE approach to rate the 
 o
n
 8 April 2020 at Universitaetsbibliothek Bern. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.m696 on 1 April 2020. Downloaded from 
RESEARCH
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
certainty in estimates from a network meta-analysis [correction in: 
J Clin Epidemiol 2018;98:162]. J Clin Epidemiol 2018;93:36-44. 
doi:10.1016/j.jclinepi.2017.10.005
33  Florez ID, Veroniki AA, Al Khalifah R, et al. Comparative effectiveness 
and safety of interventions for acute diarrhea and gastroenteritis 
in children: a systematic review and network meta-analysis. PLoS 
One 2018;13:e0207701. doi:10.1371/journal.pone.0207701
34  Bazzano LA, Hu T, Reynolds K, et al. Effects of low-carbohydrate and 
low-fat diets: a randomized trial. Ann Intern Med 2014;161:309-18. 
doi:10.7326/M14-0180
35  Yancy WSJr, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-
carbohydrate, ketogenic diet versus a low-fat diet to treat obesity 
and hyperlipidemia: a randomized, controlled trial. Ann Intern 
Med 2004;140:769-77. doi:10.7326/0003-4819-140-10-
200405180-00006
36  Anton SD, Hida A, Heekin K, et al. Effects of popular diets without specific 
calorie targets on weight loss outcomes: systematic review of findings 
from clinical trials. Nutrients 2017;9:822. doi:10.3390/nu9080822 
37  Canada’s Food Guide. Eat well, live well. Ottawa: Health Canada, 
2019. https://food-guide.canada.ca/en/.
38  Willett W, Rockström J, Loken B, et al. Food in the Anthropocene: 
the EAT-Lancet Commission on healthy diets from sustainable 
food systems. Lancet 2019;393:447-92. doi:10.1016/S0140-
6736(18)31788-4
39  Dietary Guidelines Advisory Committee, Scientific Report of the 2015 
Dietary Guidelines Advisory Committee. 2015; http://www.health.
gov/dietaryguidelines/2015-scientific-report/.
Web appendix: Supplementary material
 o
n
 8 April 2020 at Universitaetsbibliothek Bern. Protected by copyright.
http://www.bmj.com/
BM
J: first published as 10.1136/bmj.m696 on 1 April 2020. Downloaded from 
